• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians

firstwordpharmaJune 21, 2021

Tag: Vaccine , Pfizer , Health Ministry

Israel's Health Ministry said that the first batch of Pfizer's vaccine Israel sent to the Palestinian Authority as part of a larger swap deal was "completely normal" and identical to the vaccines being given to Israeli citizens, Bloomberg reported.

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians

The Palestinian Authority cancelled its exchange agreement with Israel as the doses were set to expire this month, leaving its health ministry insufficient time to use them.

However, the ministry said it sent vaccines with expiration dates that were "known, agreed upon and in accordance with the agreement between the parties."

Previous:Eisai, BMS Enter Global Anticancer ADC Alliance

Next:Solvias Acquires Chemic Labs

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio

Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio
Hualan Biological Influenza Vaccine(Split Virion),Inactivated

Hualan Biological Influenza Vaccine(Split Virion),Inactivated
Influenza Vaccine China-Hualan

Influenza Vaccine China-Hualan
Hualan inactivated flu vaccine

Hualan inactivated flu vaccine
Hualan-Biological Recombinant Hepatitis B Vaccine (Hansenula polymorpha)with High purity and good s

Hualan-Biological Recombinant Hepatitis B Vaccine (Hansenula polymorpha)with High purity and good s
Hualan Bio-H7N9 Inactivated Influenza Vaccine

Hualan Bio-H7N9 Inactivated Influenza Vaccine
Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production

Eurping GMP Washing and Drying Instrument Applied to Pharmaceutical and Vaccine Production
H7N9 Inactivated Influenza Vaccine-HUALAN BIO

H7N9 Inactivated Influenza Vaccine-HUALAN BIO
Hualan Biological Recombinant Hepatitis B Vaccine (Hansenula polymorpha)

Hualan Biological Recombinant Hepatitis B Vaccine (Hansenula polymorpha)
Freeze-Dried Live Attenuated Varicella Vaccine

Freeze-Dried Live Attenuated Varicella Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service